Marketplace®
Every story is an economic story
Dec 30, 2020

Approval of cheaper Oxford-AstraZeneca vaccine could accelerate global immunizations

A second coronavirus vaccine is approved for use in the U.K. as infection numbers across England surge. Does the Brexit deal mean Brexit uncertainty is finally over? And as Bitcoin hits a new record, we explore the future of digital currencies.

Download
Approval of cheaper Oxford-AstraZeneca vaccine could accelerate global immunizations
JOEL SAGET/AFP via Getty Images

Subscribe:

The Team

Approval of cheaper Oxford-AstraZeneca vaccine could accelerate global immunizations